Zimmer Biomet Holdings (ZBH) Other Accumulated Expenses (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Other Accumulated Expenses came in at $1.0 billion in Q1 2026, down 25.86% year-on-year from $1.4 billion in Q1 2025, and down 15.06% quarter-over-quarter from $1.2 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Other Accumulated Expenses history runs 18 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses fell 25.86% year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 25.86% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 12.69% from the prior year.
- Other Accumulated Expenses retreated to $1.0 billion in Q1 2026 per ZBH's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.5 billion in Q4 2023 and bottomed at $1.0 billion in Q1 2026.
- The 5-year median for Other Accumulated Expenses is $1.4 billion (2024), against an average of $1.3 billion.
- Across the five-year window, Other Accumulated Expenses decreased 29.96% in 2022 and climbed 29.21% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $1.4 billion in 2022, then rose by 8.84% to $1.5 billion in 2023, then dropped by 9.93% to $1.4 billion in 2024, then declined by 12.69% to $1.2 billion in 2025, then decreased by 15.06% to $1.0 billion in 2026.
- Per Business Quant, the three latest ZBH Other Accumulated Expenses figures stand at $1.0 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Zimmer Biomet Holdings | 18.10 Bn | 17.67 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.22 Bn |
| Sep 30, 2025 | 1.49 Bn |
| Jun 30, 2025 | 1.53 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.39 Bn |
| Sep 30, 2024 | 1.54 Bn |
| Jun 30, 2024 | 1.39 Bn |
| Mar 31, 2024 | 1.39 Bn |
| Dec 31, 2023 | 1.55 Bn |
| Sep 30, 2023 | 1.30 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 1.42 Bn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 1.03 Bn |
| Mar 31, 2022 | 1.12 Bn |
| Dec 31, 2021 | 1.32 Bn |
| Sep 30, 2021 | 1.44 Bn |
| Jun 30, 2021 | 1.48 Bn |